Genotyping Distribution of Hepatitis C Virus in Şanlıurfa Province and Effect of Syrian Patients
Journal Title: Viral Hepatitis Journal - Year 2019, Vol 25, Issue 2
Abstract
Objectives: Hepatitis C virus (HCV) is one of the major causes of global mortality and morbidity. The purpose of our study was to characterize the distribution of HCV genotypes in Şanlıurfa, to see the effect of patients from Syria on the distribution of HCV genotypes and to compare our results with other regions in our country. Materials and Methods: Between January 2011 and December 2015, serum samples of 312 HCV-RNA positive patients (58 Syrian patients) were sent to the laboratory for HCV genotyping. HCV genotype analysis was investigated using a commercial Abbott GT II assay (Abbott, USA). Results: The most frequent genotype was genotype 1 (69.6%), followed by genotype 2 (14.1%) and genotype 4 (10.3%). Among Syrian patients, the most prevalent genotype was genotype 4 (48.2%), followed by genotype 1 (41.4%) and genotype 5 (8.7%). Our data showed that the prevalence of genotype 1 decreased from 75% to 58.7% and genotype 2 decreased from 21.2% to 12% between 2011 and 2015, while genotype 4 increased from 1.9% to 20% and genotype 5 increased from 0% to 1.6% due to the Syrian patients. Conclusion: Our updated estimates confirm an increase in genotype 4 and genotype 5, particularly in Şanlıurfa due to the Syrian patients.
Authors and Affiliations
Osman Sezer Cirit, Ayser Uzala Mızraklı, Yalçın Vurupalmaz, Hatice Hale Gümüş, Hakan Özturhan, Ayşe Barış
Keywords
Related Articles
- EP ID EP684558
- DOI 10.4274/vhd.galenos.2019.2019.0012
- Views 160
- Downloads 0
The Evaluation of a Hundred Eleven Adult Patients with Acute Hepatitis
Objectives: We aimed to evaluate the etiological, epidemiological and laboratory characteristics of adult patients admitted to our hospital with acute hepatitis. Materials and Methods: The patients with alanine aminotra...
The Efficacy of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir with or without Ribavirin in Patients with Hepatitis C Undergoing Chronic Haemodialysis: A Single Center Experience
Objectives: Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir (PrOD) seems to be highly effective and safe in chronic haemodialysis (CHD) patients. We presented our experiences of treatment with PrOD in CHD patients. Material...
Which is More Important and Insidious in Dialysis Patients? Occult Hepatitis B or Occult Hepatitis C?
Objectives: The aim of this study was to investigate the presence of occult hepatitis B infection (OBI) and Occult hepatitis C infection (OCI) in hemodialysis patients and to determine whether there is an activation in t...
Investigating Hepatitis C, D and HIV Prevalance in Cases with Positive Hepatitis B Virus Antigen in a Tertiary Hospital and Examining Anti-HDV Positive Cases
Objectives: Hepatitis B infection has a faster and more progressive course in the presence of hepatitis C virus (HCV), HDV and human immunodeficiency virus (HIV) infections. The aim of this study was to determine anti-HC...
Relationship Between Basic Laboratory Results and Fibrosis in Chronic Hepatitis B Patients
Objectives: Liver biopsy (LB) is an important cornerstone in decision to start treatment for chronic hepatitis B (HB). Viral load and liver function tests are performed to determine the most appropriate time. In this stu...